Skip to content

BioNTech

US · BNTX #801 by market cap Listed 2019
80.96 -0.42 -0.52%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Mixed / stable
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q4).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
62.02% -0.04pp
Institutions
430 -2
As of
2026/Q4 vs. prior period

Holder types

VC/PE Fund42.17%
Individual/Insider16.22%
Mutual Fund13.88%
Hedge Fund3.29%
Public Company1.16%
Private Company0.99%
Sovereign Wealth Fund0.29%
Government Pension Fund0.19%
Other21.78%

Top holders as of 2026-03-31

AT Impf GmbH 41.02% · 101.70M sh
Ugur Sahin 15.82% · 39.22M sh
FMR 3.95% · 9.79M sh
PRIMECAP Management Company 1.51% · 3.75M sh
Dodge & Cox 1.49% · 3.69M sh
BlackRock 0.74% · 1.83M sh
Flossbach von Storch SE 0.89% · 2.23M sh
T. Rowe Price Group, Inc. 0.53% · 1.32M sh
BNP Paribas Financial Markets SNC 0.52% · 1.28M sh
Temasek Holdings 0.50% · 1.24M sh
First Trust Advisors L.P. 0.40% · 996.31K sh
Logos Global Management, L.P. 0.41% · 1.02M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 10 buys · 19 sells

NameRoleStake
AT Impf GmbH -- 41.02%
Ugur Sahin Co-Founder, CEO & Chair of the Management Board 15.82%
Sierk Pötting MD, COO & Member of Management Board 0.22%
Helmut Jeggle Independent Supervisory Board Chairman 0.13%
Ozlem Tureci Co-Founder, Chief Medical Officer & Member of Management Board 0.05%
James Timothy Ryan Chief Legal & Business Officer and Member of the Management Board 0.00%
Rudolf Staudigl Supervisory Board Member 0.00%
Anja Morawietz Supervisory Board Member 0.00%
Ryan Richardson Former Chief Strategy Officer, MD & Member of Management Board --
Salvia GmbH -- --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-08 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -63,209 $92.31–95.37
2026-10-06 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -24,000 $95.86
2026-10-05 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -93,000 $96.81–97.23
2026-10-01 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -34,000 $96.72–97.46
2026-09-29 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -66,000 $98.12–98.26
2026-09-27 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -61,000 $98.47–98.69
2026-09-23 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -69,000 $98.99–99.40
2026-09-21 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -79,000 $97.81–100.72
2026-09-17 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -64,000 $96.22–98.60
2026-09-15 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -49,000 $96.09–96.49
2026-09-13 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Private Disposition -86,000 $96.93–99.45
2026-09-09 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -20,500 $96.31
2026-09-08 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -73,000 $97.78–99.20
2026-09-03 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -76,500 $102.85–103.52
2026-09-02 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Intent to Sell (Form 144) -858,209 $103.81
2026-05-12 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Intent to Sell (Form 144) -858,209 $93.66
2026-05-11 Sierk Pötting MD, COO & Member of Management Board Other Derivative Acquisition +10,069 --
2026-05-11 Sierk Pötting MD, COO & Member of Management Board Other Derivative Acquisition +12,586 --
2026-05-11 James Timothy Ryan Chief Legal & Business Officer and Member of the Management Board Other Derivative Acquisition +10,069 --
2026-05-11 James Timothy Ryan Chief Legal & Business Officer and Member of the Management Board Other Derivative Acquisition +12,586 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

BioNTech discussion 0 comments

Add a comment